Expression of cytochrome P450 genes encoding enzymes active in the metabolism of tamoxifen in human uterine endometrium

Pharmacology and Toxicology

Volumn 82, Issue 2, 1998, Pages 93-97

  Hukkanen, Janne ^a   Mäntylä, Marjatta ^b   Kangas, Lauri ^b   Wirta, Pauli ^c   Hakkola, Jukka ^a   Paakki, Pauliina ^a   Evisalmi, Sari ^a   Pelkonen, Olavi ^a   Raunio, Hannu ^a  

^a UNIVERSITY OF OULU   (Finland)

^b ORION CORPORATION   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; ISOENZYME; MESSENGER RNA;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; ENDOMETRIUM; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA ANALYSIS; SOUTHERN BLOTTING;

EID: 0031882874     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1998.tb01404.x     Document Type: Article

References (35)

1. Ahotupa, M., P. Hirsimäki, R. Pärssinen & E. Mäntylä: Alterations of drug metabolizing and antioxidant activities during tamoxifen-induced hepatocarcinogenesis in the rat. Carcinogenesis 1994, 15, 863-868.
2. Bulun, S. E., M. S. Mahendroo & E. R. Simpson: Polymerase chain reaction amplification fails to detect aromatase cytochrome P450 transcripts in normal human endometrium or decidua. J. Clin. Endocrinol. Metab. 1993, 76, 1458-1463.
3. Carmichael, P. L., A. H. N. Ugwumadu, P. Neven, A. J. Hewer, G. K. Poon & D. H. Phillips: Lack of genotoxicity of tamoxifen in human endometrium. Cancer Res. 1996, 56, 1475-1479.
4. Cohen, C. J. & J. Rahaman: Endometrial cancer. Management of high-risk and recurrence including the tamoxifen controversy. Cancer 1995, 76, 2044-2052.
5. Crewe, H. K., S. W. Ellis, M. S. Lennard & G. T. Tucker: Variable contribution of cytochrome P450 2D6, 2C9 and 3A4 to the 4-hydroxylation of tamoxifen by human liver microsomes. Biochem. Pharmacol. 1997, 53, 171-178.
6. Guengerich, E. P.: Catalytic selectivity of human cytochrome P450 enzymes: relevance to drug metabolism and toxicity. Toxicol. Lett. 1994, 70, 133-138.
7. Hakkola, J., M. Pasanen, R. Purkunen, S. Saarikoski, O. Pelkonen, J. Mäenpää, A. Rane & H. Raunio: Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver. Biochem. Pharmacol. 1994, 48, 59-64.
8. Hakkola, J., M. Pasanen, J. Hukkanen, O. Pelkonen, J. Mäenpää, R. J. Edwards, A. R. Boobis & H. Raunio: Expression of xenobiv otic-metabolizing cytochrome P450 forms in human full-term placenta. Biochem. Pharmacol. 1996a, 51, 403-411.
9. Hakkola, J., H. Raunio, R. Purkunen, O. Pelkonen, S. Saarikoski, T. Cresteil & M. Pasanen: Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy. Biochem. Pharmacol. 1996b, 52, 379-383.
10. Hakkola, J., M. Pasanen, O. Pelkonen, J. Hukkanen, S. Evisalmi, S. Anttila, A. Rane, M. Mäntylä, R. Purkunen, S. Saarikoski, M. Tooming & H. Raunio: Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah receptor ligands in human placenta and cultured cells. Carcinogenesis 1997, 18, 391-397.
11. Hemminki, K., H. Rajaniemi, B. Lindahl & B. Moberger: Tamoxifen-induced DNA adducts in endometrial samples from breast cancer patients. Cancer Res. 1996, 56, 4374-4377.
12. Hemminki, K., H. Rajaniemi, M. Koskinen & J. Hansson: Tamoxifen-induced DNA adducts in leucocytes of breast cancer patients. Carcinogenesis 1997, 18, 9-13.
13. Hirsimäki, P., Y. Hirsimäki, L. Nieminen, S. Karlsson & E. Mäntylä: On the safety studies of the antiestrogens toremifene and tamoxifen. Scand. J. Lab. Animal Sci. 1996, 23, 147-153.
14. IARC Monographs on Evaluation of Carcinogenic Risks to Humans, Vol. 66. Some Pharmaceutical Drugs. International Agency for Research on Cancer, Lyon 1996.
15. Jordan, V. C.: Tamoxifen: toxicities and drug resistance during the treatment and prevention of breast cancer. Annu. Rev. Pharmacol. Toxicol. 1995, 35, 195-211.
16. Kikkawa, F., A. Nawa, H. Oguchi, M. Kawai, O. Maeda, N. Suganuma, T. Aoyama & Y. Tomoda: Positive correlation between cytochrome P450 2E1 mRNA level and serum estradiol level in human uterine endometrium. Oncology 1994, 51, 52-58.
17. King, C. M.: Tamoxifen and the induction of cancer. Carcinogenesis 1996, 16, 1449-1454.
18. Kleinman, D., M. Karas, M. Danilenko, A. Arbeli, C. T. Roberts, D. LeRoith, J. Levy & Y. Sharoni: Stimulation of endometrial cancer cell growth by tamoxifen is associated with increased insulin-like growth factor (IGF)-I induced tyrosine phosphorylation and regulation in IGF binding proteins. Endocrinology 1996, 137, 1089-1095.
19. Li, D., Y. Dragan, V C. Jordan, M. Wang & H. C. Pitot: Effects of chronic administration of tamoxifen and toremifene on DNA adducts in rat liver, kidney, and uterus. Cancer Res. 1997, 57, 1438-1441.
20. Liehr, J. G., M. J. Ricci, C. R. Jefcoate, E. V. Hannigan, J. A. Hokanson & B. T. Zhu: 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: implications for the mechanism of uterine tumorigenesis. Proc. Natl. Acad. Sci. USA 1995, 92, 9220-9224.
21. Mani, C., R. Pearce, A. Parkinson & D. Kupfer: Involvement of cytochrome P4503A in catalysis of tamoxifen activation and covalent binding to rat and human liver microsomes. Carcinogenesis 1994, 15, 2715-2720.
22. Mass, M. J., N. T. Rodgers & D. G. Kaufman: Benzo[a]pyrene metabolism in organ cultures of human endometrium. Chem. Biol. Interact. 1981, 33, 195-205.
23. Mäntylä, E., S. Karlsson & L. Nieminen: Induction of endometrial cancer by tamoxifen in the rat. Eds.: J. J. Li, S. A. Li, J.-Å. Gustafsson, N. Nandi and L. I. Sekely. In: Hormonal Carcinogenesis II. Springer-Verlag, New York, 1996, pp. 442-445.
24. Nelson, D. R., L. Koymans, T. Kamataki, J. J. Stegeman, R. Feyereisen, D. J. Waxman, M. R. Waterman, O. Gotoh, M. J. Coon, R. W. Estabrook, I.C. Gunsalus & D. W. Nebert: P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 1996, 6, 1-42.
25. Nephew, K. P., T. C. Polek & S. A. Khan: Tamoxifen-induced protooncogene expression persists in uterine endometrial epithelium. Endocrinology, 1996, 137, 219-224.
26. Nuwaysir, E. F., Y. P. Dragan, C. R. Jefcoate, V. C. Jordan & H. C. Pitot: Effects of tamoxifen administration on the expression of xenobiotic metabolizing enzymes in rat liver. Cancer Res. 1996, 55, 1780-1786.
27. 5-ethyl]-tamoxifen implicates α-hydroxylation of the ethyl group as a major pathway of tamoxifen activation to a liver carcinogen. Carcinogenesis 1994, 15, 1487-1492.
28. Phillips, D. H., P. L. Carmichael, A. Hewer, K. J. Cole, I. R. Hardcastle, G. K. Poon, A. Keogh & A. J. Strain: Activation of tamoxifen and its metabolite α-hydroxytamoxifen to DNA-binding products: comparisons between human, rat and mouse hepatocytes. Carcinogenesis 1996, 17, 89-94.
29. Raunio, H., K. Husgafvel-Pursiainen, S. Anttila, E. Hietanen, A. Hirvonen & O. Pelkonen: Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility-review. Gene 1995, 159, 113-121.
30. Rutqvist, L. E., H. Johansson, T. Signomklao, U. Johansson, T. Fornander & N. Wilking: Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. J. Natl. Cancer Inst. 1995, 87, 645-651.
31. Schuetz, J. D., S. Kauma & P. S. Guzelian: Identification of the fetal liver cytochrome CYP3A7 in human endometrium and placenta. J. Clin. Invest. 1993, 92, 1018-1024.
32. Shimada, T., C. L. Hayes, H. Yamazaki, S. Amin, S. S. Hecht, F. P. Guengerich & T. R. Sutter: Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res. 1996, 56, 2979-2984.
33. Styles, J. A., A. Davies, C. K. Lim, F. De Matteis, L. A. Stanley, I. N.H . White, Z.-X. Yuan & L. L. Smith: Genotoxicity of tamoxifen, tamoxifen epoxide and toremifene in human lymphoblastoid cells containing human cytochrome P450s. Carcinogenesis 1994, 15, 5-9.
34. White, I. N. H., A. Davies, L. L. Smith, S. Dawson & F. De Matteis: Induction of CYP2B1 and 3A1, and associated monooxygenase activities by tamoxifen and certain analogues in the livers of female rats and mice. Biochem. Pharmacol. 1993, 45, 21-30.
35. 14C]tamoxifen to liver microsomes and the forms of cytochrome P450 involved. Biochem. Pharmacol. 1995, 49, 1035-1042.